Myocardial infarction and gastro-intestinal bleeding risks associated with aspirin use among elderly individuals with type 2 diabetes.

about

Risk of gastrointestinal bleeding and cardiovascular events due to NSAIDs in the diabetic elderly population

P2860

Q36405796-A5C994C4-5182-4070-AA62-80DEE6D4370D

P2860

Myocardial infarction and gastro-intestinal bleeding risks associated with aspirin use among elderly individuals with type 2 diabetes.

Item

http://www.wikidata.org/entity/Q43563736

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Myocardial infarction and gast ...... ividuals with type 2 diabetes.

@en

Myocardial infarction and gast ...... ividuals with type 2 diabetes.

@nl

type

Item

label

Myocardial infarction and gast ...... ividuals with type 2 diabetes.

@en

Myocardial infarction and gast ...... ividuals with type 2 diabetes.

@nl

prefLabel

Myocardial infarction and gast ...... ividuals with type 2 diabetes.

@en

Myocardial infarction and gast ...... ividuals with type 2 diabetes.

@nl

P1476

Myocardial infarction and gast ...... ividuals with type 2 diabetes.

@en

P2093

Jean-Pierre Grégoire

http://www.w3.org/2001/XMLSchema#string

Jocelyne Moisan

http://www.w3.org/2001/XMLSchema#string

Paul Poirier

http://www.w3.org/2001/XMLSchema#string

P2860

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial

Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies

Low-dose aspirin for the prevention of atherothrombosis

AHA/ADA vs. ESC/EASD recommendations on aspirin as a primary prevention strategy in people with diabetes: how the same data generate divergent conclusions

Final report on the aspirin component of the ongoing Physicians' Health Study

Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data.

Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: a systematic review and meta-analysis

Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial.

Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study

P304

335-340

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/07853890.2014.902636

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Caroline Sirois

P577

2014-05-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24785356

http://www.w3.org/2001/XMLSchema#string

P921

Aat atak

type-2 diabetes

Myocardial infarction and gastro-intestinal bleeding risks associated with aspirin use among elderly individuals with type 2 diabetes.

about

P2860

P2860

Myocardial infarction and gastro-intestinal bleeding risks associated with aspirin use among elderly individuals with type 2 diabetes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921